Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Wainwright EN"'
Autor:
Guirguis AA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia.; Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Victoria, Australia., Ofir-Rosenfeld Y; Storm Therapeutics Ltd, Cambridge, United Kingdom., Knezevic K; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Blackaby W; Storm Therapeutics Ltd, Cambridge, United Kingdom., Hardick D; Storm Therapeutics Ltd, Cambridge, United Kingdom., Chan YC; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia., Motazedian A; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia., Gillespie A; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Vassiliadis D; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia., Lam EYN; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia., Tran K; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia., Andrews B; Storm Therapeutics Ltd, Cambridge, United Kingdom., Harbour ME; Storm Therapeutics Ltd, Cambridge, United Kingdom., Vasiliauskaite L; Storm Therapeutics Ltd, Cambridge, United Kingdom., Saunders CJ; Storm Therapeutics Ltd, Cambridge, United Kingdom., Tsagkogeorga G; Storm Therapeutics Ltd, Cambridge, United Kingdom.; Milner Therapeutics Institute, University of Cambridge, Cambridge, United Kingdom., Azevedo A; Storm Therapeutics Ltd, Cambridge, United Kingdom., Obacz J; Storm Therapeutics Ltd, Cambridge, United Kingdom., Pilka ES; Evotec (UK) Ltd, Abingdon, United Kingdom., Carkill M; Charles River Laboratories, Portishead, United -Kingdom., MacPherson L; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia., Wainwright EN; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia., Liddicoat B; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia., Blyth BJ; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia., Albertella MR; Storm Therapeutics Ltd, Cambridge, United Kingdom., Rausch O; Storm Therapeutics Ltd, Cambridge, United Kingdom., Dawson MA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia.; Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Centre for Cancer Research, University of Melbourne, Melbourne, -Victoria, Australia.
Publikováno v:
Cancer discovery [Cancer Discov] 2023 Oct 05; Vol. 13 (10), pp. 2228-2247.
Autor:
Chan KL; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia; Department of Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC 3000, Australia., Gomez J; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Division of Genome Science and Cancer, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT 2601, Australia., Cardinez C; Division of Genome Science and Cancer, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT 2601, Australia., Kumari N; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Sparbier CE; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Lam EYN; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Yeung MM; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Garciaz S; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Aix-Marseille University, INSERM U1068, CNRS, Institut Paoli-Calmettes, 13009 Marseille, France., Kuzich JA; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Ong DM; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC 3004, Australia; Department of Haematology, The Alfred Hospital, Melbourne, VIC 3004, Australia., Brown FC; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC 3004, Australia., Chan YC; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Vassiliadis D; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Wainwright EN; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Motazedian A; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Gillespie A; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Fennell KA; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Lai J; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., House IG; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Macpherson L; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Ang CS; Melbourne Mass Spectrometry and Proteomics Facility, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC 3010, Australia., Dawson SJ; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia; Centre for Cancer Research, The University of Melbourne, Parkville, VIC 3000, Australia., Beavis PA; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Wei AH; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC 3004, Australia; Department of Haematology, The Alfred Hospital, Melbourne, VIC 3004, Australia., Burr ML; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia; Division of Genome Science and Cancer, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT 2601, Australia; Department of Anatomical Pathology, ACT Pathology, Canberra Health Services, Canberra, ACT 2606, Australia. Electronic address: marian.burr@anu.edu.au., Dawson MA; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia; Department of Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC 3000, Australia; Centre for Cancer Research, The University of Melbourne, Parkville, VIC 3000, Australia. Electronic address: mark.dawson@petermac.org.
Publikováno v:
Cancer cell [Cancer Cell] 2022 Oct 10; Vol. 40 (10), pp. 1190-1206.e9. Date of Electronic Publication: 2022 Sep 29.
Autor:
Chau TCY; Division of Genomics of Development and Disease, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland, Australia., Baek S; Division of Genomics of Development and Disease, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland, Australia., Coxam B; Division of Genomics of Development and Disease, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland, Australia., Skoczylas R; Division of Genomics of Development and Disease, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland, Australia., Rondon-Galeano M; Division of Genomics of Development and Disease, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland, Australia.; Organogenesis and Cancer Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Bower NI; Division of Genomics of Development and Disease, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland, Australia., Wainwright EN; Division of Genomics of Development and Disease, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland, Australia., Stacker SA; Tumour Angiogenesis and Microenvironment Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Surgery, Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Cooper HM; The University of Queensland, Queensland Brain Institute, St Lucia, Queensland, Australia., Koopman PA; Division of Genomics of Development and Disease, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland, Australia., Lagendijk AK; Division of Cell and Developmental Biology, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland, Australia., Harvey NL; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia., François M; Division of Genomics of Development and Disease, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland, Australia.; David Richmond Laboratory for Cardiovascular Development; Gene Regulation and Editing Program, Centenary Institute, Sydney, New South Wales, Australia., Hogan BM; Division of Genomics of Development and Disease, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland, Australia.; Organogenesis and Cancer Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Department of Anatomy and Physiology, University of Melbourne, Melbourne, Victoria, Australia.
Publikováno v:
Developmental dynamics : an official publication of the American Association of Anatomists [Dev Dyn] 2022 Feb; Vol. 251 (2), pp. 336-349. Date of Electronic Publication: 2021 Jul 16.
Autor:
Morales Torres C; Cancer Epigenetics Laboratory, Francis Crick Institute, London, NW1 1AT, UK., Wu MY; High-Throughput Screening, Francis Crick Institute, London, NW1 1AT, UK., Hobor S; Cancer Evolution and Genome Instability Laboratory, Francis Crick Institute, London, NW1 1AT, UK., Wainwright EN; Cancer Epigenetics Laboratory, Francis Crick Institute, London, NW1 1AT, UK., Martin MJ; Oncology R&D, AstraZeneca, Cambridge, CB2 0RE, UK., Patel H; Bioinformatics and Biostatistics, Francis Crick Institute, London, NW1 1AT, UK., Grey W; Haematopoietic Stem Cell Laboratory, Francis Crick Institute, London, NW1 1AT, UK., Grönroos E; Cancer Evolution and Genome Instability Laboratory, Francis Crick Institute, London, NW1 1AT, UK., Howell S; Proteomics, Francis Crick Institute, London, NW1 1AT, UK., Carvalho J; Experimental Histopathology, Francis Crick Institute, London, NW1 1AT, UK., Snijders AP; Proteomics, Francis Crick Institute, London, NW1 1AT, UK., Bustin M; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20814, USA., Bonnet D; Haematopoietic Stem Cell Laboratory, Francis Crick Institute, London, NW1 1AT, UK., Smith PD; Oncology R&D, AstraZeneca, Cambridge, CB2 0RE, UK., Swanton C; Cancer Evolution and Genome Instability Laboratory, Francis Crick Institute, London, NW1 1AT, UK.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, University College London, London, WC1E 6BT, UK., Howell M; High-Throughput Screening, Francis Crick Institute, London, NW1 1AT, UK., Scaffidi P; Cancer Epigenetics Laboratory, Francis Crick Institute, London, NW1 1AT, UK. Paola.Scaffidi@crick.ac.uk.; UCL Cancer Institute, University College London, London, WC1E 6DD, UK. Paola.Scaffidi@crick.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2020 Apr 14; Vol. 11 (1), pp. 1792. Date of Electronic Publication: 2020 Apr 14.
Autor:
Mortimer T; Cancer Epigenetics Laboratory, The Francis Crick Institute, London, UK., Wainwright EN; Cancer Epigenetics Laboratory, The Francis Crick Institute, London, UK., Patel H; Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK., Siow BM; In Vivo Imaging, The Francis Crick Institute, London, UK., Jaunmuktane Z; Department of Clinical and Movement Neurosciences, Queen Square Brain Bank, UCL Queen Square Institute of Neurology, London, UK.; Division of Neuropathology, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK., Brandner S; Division of Neuropathology, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK.; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK., Scaffidi P; Cancer Epigenetics Laboratory, The Francis Crick Institute, London, UK.; UCL Cancer Institute, University College London, London, UK.
Publikováno v:
EMBO reports [EMBO Rep] 2019 Oct 04; Vol. 20 (10), pp. e48155. Date of Electronic Publication: 2019 Aug 29.
Autor:
Wainwright EN; Cancer Epigenetics Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Scaffidi P; Cancer Epigenetics Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK; UCL Cancer Institute, University College London, London WC1E 6DD, UK. Electronic address: Paola.Scaffidi@crick.ac.uk.
Publikováno v:
Trends in cancer [Trends Cancer] 2017 May; Vol. 3 (5), pp. 372-386. Date of Electronic Publication: 2017 May 05.
Autor:
Wainwright EN; Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia., Wilhelm D; Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia., Combes AN; Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia., Little MH; Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia., Koopman P; Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia. Electronic address: p.koopman@imb.uq.edu.au.
Publikováno v:
Developmental biology [Dev Biol] 2015 Aug 15; Vol. 404 (2), pp. 88-102. Date of Electronic Publication: 2015 Jun 23.
Autor:
McClelland KS; Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia., Wainwright EN; Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia., Bowles J; Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia., Koopman P; Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.
Publikováno v:
PloS one [PLoS One] 2015 Jan 28; Vol. 10 (1), pp. e0114932. Date of Electronic Publication: 2015 Jan 28 (Print Publication: 2015).
Autor:
Wainwright EN; Institute for Molecular Bioscience, The University of Queensland, Brisbane QLD 4072, Australia., Svingen T; Institute for Molecular Bioscience, The University of Queensland, Brisbane QLD 4072, Australia., Ng ET; Institute for Molecular Bioscience, The University of Queensland, Brisbane QLD 4072, Australia., Wicking C; Institute for Molecular Bioscience, The University of Queensland, Brisbane QLD 4072, Australia., Koopman P; Institute for Molecular Bioscience, The University of Queensland, Brisbane QLD 4072, Australia. Electronic address: p.koopman@imb.uq.edu.au.
Publikováno v:
Developmental biology [Dev Biol] 2014 Nov 15; Vol. 395 (2), pp. 342-54. Date of Electronic Publication: 2014 Sep 16.
Autor:
Wainwright EN; Division of Molecular Genetics and Development, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia., Jorgensen JS, Kim Y, Truong V, Bagheri-Fam S, Davidson T, Svingen T, Fernandez-Valverde SL, McClelland KS, Taft RJ, Harley VR, Koopman P, Wilhelm D
Publikováno v:
Biology of reproduction [Biol Reprod] 2013 Aug 15; Vol. 89 (2), pp. 34. Date of Electronic Publication: 2013 Aug 15 (Print Publication: 2013).